Live at ViVE: Regulatory Oversight for Digital Health Innovations—with Troy Tazbaz
Historically, the FDA was used to approving material health products and medical devices.
But with the rise of health technology, including generative AI, the department must approach regulations differently to ensure that digital products remain safe and effective once they’re on the market.
So, how does the FDA think about monitoring digital health products and diagnostics? How do they assess the risks associated with innovations in the healthcare space?
Troy Tazbaz is Director of the Digital Health Center of Excellence at the FDA, where he's responsible for envisioning a future of safe and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.